pennytobuck Newsletter __ MYGN, Myriad Genetics, Inc. ** On its first quarter fiscal 2012, MYGN posted record revenue of $110.5 million, an increase of 20 percent year over year. Operating income was $41.5 million, an increase of 17 percent from … Continue reading
↧
